
Learn the Hindquarter amputation with pedicled fillet flap for clear cell chondrosarcoma of the proximal femur surgical technique with step by step instructions on OrthOracle. Our e-learning platform contains high resolution images and a certified CME of the Hindquarter amputation with pedicled fillet flap for clear cell chondrosarcoma of the proximal femur surgical procedure.
Pelvic resections remain the most challenging of procedures for patients and surgeons alike. Regrettably there are occasions when a tumour cannot be excised without sacrificing the limb, necessitating a hindquarter amputation.
When tumours arise in the limbs, oncology surgeons need to consider the contamination of each individual compartment when planning the surgical strategy. Where a tumour has undergone inadvertent surgery, contamination of many compartments can occur and significantly impact upon the potential to salvage a limb. At the hip, if multiple compartments and the hip joint are contaminated by tumour, then only a hindquarter amputation or rotationplasty (where a femoral tumour is excised and the ankle rotated to become and functional ‘knee’ joint) offer a curative option for a chemo-radiotherapy insensitive tumour such as clear cell chondrosarcoma. In principle, limb-salvage may still be possible in chemo-radiosensitive tumours such as Ewing’s sarcoma or in some oligometastatic bone tumours.
The British Orthopaedic Oncology Society have produced helpful guidelines to minimise the chance of inadvertently operating on tumour cases, with the attendant risks including compromising the possibility of limb salvage surgery. The key point is that prodromal pain and injury mechanisms not in keeping with traumatic fractures are indicative of pathological fractures i.e. due to an underlying cause such as malignancy (or osteoporosis, infection, metabolic disease, dysplasia, Paget’s disease etc). In such cases there is no rush to stabilise fractures (STOP), patients should be investigated throughly including whole-body staging (SCAN) and discussed with their treating oncologist if metastatic or with a specialist orthopaedic oncologist if solitary (PLAN).
OrthOracle readers will also find the following operative techniques of interest:
Computer navigated P1 hemipelvectomy for chondrosarcoma and GRAFTJACKET (Wright Medical) reconstruction
Computer navigated Hemi-pelvectomy for Ewings sarcoma
Hindquarter amputation (for pelvic soft tissue sarcoma)

INDICATIONS
The indications for hindquarter amputation are either for curative resection of malignant tumours of bone or soft-tissue where limb-salvage surgery would compromise oncological outcomes, or (rarely) for palliation in the presence of metastatic disease to improve pain and quality of life. More recently, hindquarter amputation has been used as treatment for failed limb-salvage surgery, particularly pelvic reconstruction, in the presence of infection.
A variety of flaps have been described, depending on the residual blood supply after resection and where the tumour was located. The most common is the posterior flap based on gluteus maximus supplied by the superior gluteal pedicle. An alternative is an anterior thigh flap based on the femoral vessels. Rarely an adductor flap based on the obturator vessels is required where the superior gluteal pedicle and femoral vessels are involved by the tumour. Even more rarely the wound is closed using a ‘fillet flap’ utilising the redundant calf tissue which can be pedicled (as in this case) or a ‘free’ flap transfer requiring vascular anastomosis.
SYMPTOMS & EXAMINATION
A common early symptom is pain which often follows an insidious, intractable course from functional pain, to rest pain and finally night pain. Due to the rarity of the diagnosis, patients are often falsely reassured or under investigated, at least at the initial stages of the disease. Due to the distensibility of the pelvic cavity, tumours can reach a large size before a mass becomes palpable. The presence of a mass often stimulates further investigation. Patients rarely present with systemic symptoms of fevers, night sweats or weight loss except in advanced disease. Examination findings in patients with pelvic tumours are often non-specific. Acetabular involvement will often result in a limp and an irritable range of movements. Abdominal examination often demonstrates a mass in close association with the pelvis. The mass is often firm, irregular and heterogenous in texture, and fixed to underlying structures. Examination of the local lymph node structures occasionally reveals lymphadenopathy though this a rare feature. A full neurological examination should be completed as tumours will often compress neurological structures, or invade directly into the sacrum. The lower limb vascularity, both venous and arterial should be assessed looking in particular for the presence of vascular insufficiency or venous engorgement suggestive of pelvic vessels compression.
IMAGING
Local staging: Radiographs should form the first line investigation for any suspected bone sarcoma and often these will identify areas of lysis suggestive of infiltration. Cross-sectional imaging for local staging should comprise an MRI scan, including the whole bone including the hip and knee joint, although where pelvic surgery is contemplated, the whole pelvis and sacrum will need MRI as well. Tumours will appear as an enlarged high signal mass with soft tissue extension and in the case of tumours invading bone, lysis, destruction and oedema within osseous structures.
Full distal staging should be completed before discussing management. In the case of soft-tissue sarcomas, this should comprise CT of the chest. Whole body bone scintigraphy is indicated in most primary bone tumours to distally stage the rest of the skeleton. Whole body imaging is often not indicated for soft-tissue sarcomas except for certain histological variants (e.g. myxoid liposarcomas, leiomyosarcomas) in which whole body MRI or whole body PET-CT imaging is required. Increasingly whole body MRI is used to stage Ewing’s sarcomas of bone.
ALTERNATIVE OPERATIVE TREATMENT
Limb-salvage is always the primary aim of surgical treatment at the outset. The principles of surgical management should be to remove the tumour in its entirety, with a clear margin with a degree of function post-operation that is acceptable to the patient. Where this is not achievable with limb-salvage, an amputation should be considered. In the case of pelvic sarcoma surgery the indications for hindquarter amputation are involvement of two of the following: the hip joint, sciatic nerve or femoral vessels. This may be offered after the administration of neo-adjuvant radiotherapy which would be aimed at arresting tumour growth, reducing the risk of local recurrence, or rarely to downstage disease and allow limb-salvage surgery. In advanced disease, hindquarter amputation may occasionally be offered to palliate particularly in the presence of intractable pain and/or tumour fungation.
NON-OPERATIVE MANAGEMENT
Non-operative management may be considered in the presence of advanced metastatic disease, or where hindquarter amputation is not acceptable for the patient. In such cases, the patient may receive radiotherapy with palliative intent.
CONTRAINDICATIONS
Contraindications to hindquarter amputation are patient related, where the procedure is unacceptable to the patient or where the risk of peri-operative mortality is deemed too high to undertake the procedure. Relative contraindications now include patients in whom only palliative pain relief is achievable as recent literature has highlighted that 1 in 3 palliative hindquarter patients die within 30 days of surgery (Kiiski et al. Surgical and oncological outcomes after hindquarter amputation for pelvic sarcoma. Bone Joint J 2020;102-B:6, 788-794).

Patients are positioned in a sloppy lateral position to allow access to the midline anteriorly and posteriorly. After general anaesthesia, both spinal and epidural anaesthesia combined with adrenaline infusion is commenced for hypotensive anaesthesia, proven to reduce blood loss and transfusion requirements (Freeman et al. Hypotensive Epidural Anesthesia Reduces Blood Loss in Pelvic and Sacral Bone Tumor Resections. Clin Orthop Relat Res. 2017 Mar;475(3): 634–640). Bowel preparation is given pre-operatively to cleanse the colon, urinary catheters decompress the bladder for safety and central venous and arterial monitoring is inserted.
After intravenous antibiotics (vancomycin and meropenem) and tranexamic acid, mechanical thromboprohylaxis pumps on the contralateral calf and forced air warming are applied. The patient is positioned in an ultra-clean air flow theatre.

Mechanical and venous thromboembolism prophylaxis using thromboembolic compression stockings for 6 weeks with flowtrons or foot pumps whilst in bed and chemical thromboprophylaxis (low molecular weight heparin) for 28 days, (see Lex et al. Venous Thromboembolism in Orthopaedic Oncology. Bone Joint J 2020;102-B(12)1743:–1751.)
Up titrate the dose of pregabalin and according to levels of phantom limb pain.
Await histological analysis.
Check bowel sounds before recommencing light diet in 24-36 hours.
Removal of sutures at two weeks.
Wound review on ward after seven days with plastics team.
Routine high grade bone sarcoma surveillance (three monthly CXRs for two years with clinical examination, then six monthly until year five, ten annually until ten years).

British Orthopaedic Association guidance is very clear: prodromal pain and injury mechanisms not in keeping with the fracture sustained are indicators of pathological fractures, which should be investigated thoroughly to identify the potential malignant, infective or metabolic cause. This is to prevent inadvertent surgery that may compromise a potential curative resection, leading to more extensive and morbid surgery.
Hindquarter amputations are the most extensive procedures in the armoury of orthopaedic oncologists for controlling pelvic and proximal femoral tumours and certainly not undertaken lightly, nor in the absence of a multi-disciplinary team discussion. This is a challenging discussion to broach with patients usually aided with appropriate imaging to enable the patient to visualise the extent of the tumour.
Outcomes from this procedure are poor: the morbidity and mortality are higher than any other orthopaedic procedure, 30-day mortality is 1% at our institution (Kiiski et al. Surgical and oncological outcomes after hindquarter amputation for pelvic sarcoma. Bone & Joint Journal 2020;102:788-794). One in two patients suffer a complication and one in four require further surgery.
The most frequent indication for HQA is to offer resection of bone or soft-tissue tumours with curative intent, meaning that patients are carefully selected particularly if they have staging imaging indicative of pulmonary metastases meaning the procedure would be palliative (Grimer et al. Hindquarter amputation. Bone & Joint Journal 2013; 95-B:1:127-131). Palliative hindquarters are associated with a 30-day mortality rate of 1/3.
Controversy and concern about this operation, rightly, persists in surgical literature: in patients younger than 65 years with localised disease (non-metastatic) it remains an acceptable curative surgical option, although authors have urged caution in patients aged greater than 65 years with larger tumours (>15cm) who have worse overall survival after HQA (van Houdt, WJ et al. Oncologic Outcome and Quality of Life After Hindquarter Amputation for Sarcoma: Is it Worth it?. Ann Surg Oncol 2018;25:378–386).
Reference
- orthoracle.com






























































































